asreview.nl

What It Is

ASReview is an open-source AI tool focused on screening for systematic reviews. Its official messaging emphasizes “Screen faster with ASReview,” meaning it uses AI assistance to speed up the literature screening process. It targets different types of systematic review users and offers tool formats ranging from AI-aided reviews to crowdscreening.

Core Capabilities and Use Cases

Based on the available content, ASReview’s core value is bringing AI into the screening stage of systematic reviews, helping researchers process candidate literature more quickly. Typical use cases include researchers conducting systematic reviews, evidence synthesis, AI-assisted initial literature screening, and multi-person or crowdsourced screening. Its positioning as “open-source tools” is especially important for academic research, as open source generally supports greater methodological transparency, reproducibility, and internal deployment evaluation within teams.

Pricing, Chinese Support, and Integrations

The captured page content does not provide pricing, free quota, trial policy, or commercial service information, so its billing model cannot be determined. There is also no clear information on a Chinese interface, Chinese-language literature handling, APIs, third-party integrations, or data privacy policies. For teams in China, these are key points to verify before formal adoption, especially whether literature data is uploaded to the cloud, whether local deployment is supported, and whether it can connect with workflows such as Zotero, Rayyan, or Covidence.

Pros and Cons

Its strengths are a clearly defined vertical use case and a focus on systematic review screening. It also emphasizes open source, making it suitable for research institutions, evidence-based medicine teams, and users who need auditable workflows. The limitation is that the currently captured text does not provide enough information about its specific AI models, screening quality, recall performance, or mechanisms for controlling missed or incorrect screening decisions. Details on support services and deployment are also lacking.

Who It’s For and Access from China

ASReview is better suited to universities, hospitals, research institutions, and evidence synthesis teams that conduct systematic reviews. Access from China is unknown; if the official website or related dependencies are unstable, users may need a proxy or look for a locally deployable version. The source text does not provide alternative product information, so users are advised to compare it with other systematic review screening tools based on their own workflow needs.